Effective combination therapy does not seem to provide any benefit for the treatment of Stenotrophomonas maltophilia pneumonia.

Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia.

  • Shah MD. et al.
  • Rédigé par : Dr Olivier Leroy
Stenotrophomonas maltophilia is an emerging nosocomial pathogen more and more often responsible for respiratory tract infections. It is intrinsically resistant to numerous antibiotics, making it potentially challenging to treat. The debate between combination therapy (CT) and monotherapy (MT) continues. Microbiological data and some clinical data concerning bacteremia seem to be in favour of CT...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.

Déjà inscrit / Already registered ?

Créer un compte / Create an account

Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.